Company Overview of CellProthera SAS
CellProthera SAS, a medical biotech company, develops and markets therapeutic solutions for the regeneration of organs damaged by disease or trauma from autologous blood peripheral stem cells. The company focuses on the use of blood peripheral stem cells for cardiac diseases; and offers ProtheraCytes, an advanced therapy medicinal product (ATMP) which is used in myocardial muscle for the recovery of the cardiac function. CellProthera SAS was founded in 2008 and is based in Mulhouse, France.
12, Rue du Parc
Founded in 2008
33 3 69 71 97 71
33 3 89 52 64 15
Key Executives for CellProthera SAS
CellProthera SAS Key Developments
Similar Private Companies By Industry
|Acticor Biotech SAS||Europe|
|Aelis Farma S.A.S.||Europe|
|Aenitis Technologies SAS||Europe|
Recent Private Companies Transactions
December 31, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CellProthera SAS, please visit www.cellprothera.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.